Tiga Healthcare Technologies’ Post

Getting Ahead of the Ever-changing Landscape of Healthcare Technology: Actionable Strategies for Overcoming Challenges https://hubs.la/Q02tFyp20

Data plays a critical role in the development of healthcare technology, enhancing treatments and elevating patient care standards. Regarding this, understanding the different types of healthcare data with their unique traits will enable healthcare organizations to optimize operations, and drive innovation in the healthcare industry. 👉 So what are you waiting for? Take the lead in the healthtech race by exploring data types and their applications with KMS Healthcare right now: https://hubs.la/Q02sZ_t10 #healthdata #healthtech

🌟 Europe! It’s time to boldly build together to create a better and brighter system of care. 🌟 It was energizing for Alexandre Momeni and myself to meet with so many talented entrepreneurs and leaders across pharma, payers, providers and policy at HLTH Europe, all committed to making a difference in European healthcare. Here are a few of takeaways: ✅ An ambitious new generation of European digital health innovators is emerging. Following in the footsteps of Sword Health, Alan and Doctolib, companies like Doccla, Nabla, Corti and Causaly are pioneering world-class solutions to bridge the critical gaps in Europe’s healthcare infrastructure. They are creating a future instead of optimizing the present and their success will raise the bar, attracting more talent and investment in the space. ✅ Our academic health systems are undergoing a ‘renAIssance’. Lighthouse health systems like Sheba Medical Center, Tel Hashomer, Charité - Universitätsmedizin Berlin, Guy's and St Thomas' NHS Foundation Trust and Greater Paris University Hospitals - AP-HP are re-imagining their business models to shift care out of the hospital, making strategic investments and embracing innovative solutions to leapfrog their most pressing challenges, including with (Gen)AI. AI is not just a tool for efficiency; it’s a catalyst for more effective healthcare. ✅ Radical collaboration is the path to success. HLTH, with over 3,500 attendees from over 60 countries convening in Amsterdam, is proof that when we are bold and join together as a community, bringing the best minds and hearts together to engage and share ideas, we make progress. This is critical in Europe where the geographic and regulatory complexities of the market means greater coordination and intentionality is needed to achieve real system-level change instead of diffuse pockets of innovation. As an investor in European digital health for over a decade, I’m excited by how vibrant the ecosystem is becoming. At General Catalyst, we are committed to creating, investing, partnering and operating to enhance the resilience of European healthcare — all in the pursuit of Health Assurance. Let’s seize this moment!

What advances in healthcare will make an impact in 2025? Find out in a new report from Onyx and published in Fortune. 36 healthcare CEOs, including our own Stephen Gillett, share what they’re working on and their top priorities in the coming year. https://veri.ly/4g0pPL0 #PrecisionHealth #HealthTech #HealthcareInnovation

InnoScot Health is partnering on the development of a new network that will support and enhance the understanding of digital health innovators as they look to navigate the complex regulatory environment with their new products. The proposed network – led by University of Glasgow’s Digital Health Validation Lab (DHVL) – is in its first phase and is currently aiming to identify and address areas which are considered particularly challenging within the digital health regulatory landscape before looking to progress to a second phase. The dynamic and rapidly evolving nature of such technologies has given rise to specific regulatory complexities faced by innovators and companies when developing fresh products. By enabling a network that develops regulatory science approaches spanning the entire product development cycle, DHVL will aim to help innovators deliver high-impact innovations that can be scaled up to benefit the UK and worldwide healthcare systems. However, in order to determine the network’s priorities, innovators across industry, academia, and healthcare are first invited to undertake a new survey that will help to determine the network’s priorities, ensuring that it focuses on priority areas of need. The survey will serve to build an understanding of the key regulatory needs of digital health innovators. A key feature of the network will be DHVL’s ability to generate real world clinical evidence to support regulatory submissions. This requirement for the digital health market is rapidly expanding, and is critical in assuring the safety, effectiveness, and compliance of digital health technologies such as apps, medical devices, and software solutions. The network is being developed alongside partners including Canon Medical Research Europe, CENSIS, Filament STAC - Smart Things Accelerator Centre, and NHS Greater Glasgow and Clyde. This development work is funded by Innovate UK as part of its UK Regulatory Science and Innovation Networks programme – a key initiative for harnessing the power of regulatory science to generate evidence and intelligence which informs regulatory policy and practice. Read more and take part 👉 https://lnkd.in/eKmu-v7s

InnoScot Health is partnering on the development of a new network that will support and enhance the understanding of digital health innovators as they look to navigate the complex regulatory environment with their new products. The proposed network – led by University of Glasgow’s Digital Health Validation Lab (DHVL) – is in its first phase and is currently aiming to identify and address areas which are considered particularly challenging within the digital health regulatory landscape before looking to progress to a second phase. The dynamic and rapidly evolving nature of such technologies has given rise to specific regulatory complexities faced by innovators and companies when developing fresh products. By enabling a network that develops regulatory science approaches spanning the entire product development cycle, DHVL will aim to help innovators deliver high-impact innovations that can be scaled up to benefit the UK and worldwide healthcare systems. However, in order to determine the network’s priorities, innovators across industry, academia, and healthcare are first invited to undertake a new survey that will help to determine the network’s priorities, ensuring that it focuses on priority areas of need. The survey will serve to build an understanding of the key regulatory needs of digital health innovators. A key feature of the network will be DHVL’s ability to generate real world clinical evidence to support regulatory submissions. This requirement for the digital health market is rapidly expanding, and is critical in assuring the safety, effectiveness, and compliance of digital health technologies such as apps, medical devices, and software solutions. The network is being developed alongside partners including Canon Medical Research Europe, CENSIS, Filament STAC - Smart Things Accelerator Centre, and NHS Greater Glasgow and Clyde. This development work is funded by Innovate UK as part of its UK Regulatory Science and Innovation Networks programme – a key initiative for harnessing the power of regulatory science to generate evidence and intelligence which informs regulatory policy and practice. Read more and take part 👉 https://lnkd.in/eKmu-v7s

H2O is making waves in revolutionising healthcare decision-making! 🌊 Traditionally, patient-reported outcomes haven't always been seamlessly integrated into clinical decision-making. However, with rapid technological advancements, we now have the opportunity to change this. The H2O project aims to provide a trusted platform for patients to register crucial information about their health journey - symptoms, treatment experiences, and preferences - directly to their healthcare providers. Here's how H2O is transforming the patient experience: 🔍 Personal Tracking: Patients can track their condition throughout diagnosis, treatment, and follow-up, spotting patterns that could reveal personalised triggers or manifestations of symptoms. 🤝 Comparison and Understanding, by comparing their experiences with other patients on H2O, individuals gain insights into the broader burden of disease and assess the quality of care they're receiving. 💬 Informed Discussions, armed with data and insights from H2O, patients can engage in more informed discussions with their physicians, ensuring their thoughts and preferences are central to treatment decisions. 📊 Integrated Health Information, with access to their health data in one place, patients can easily reference it during visits to any healthcare professional, streamlining their care journey. 🌐 Advocacy and Guidance, national and international patient organisations can leverage aggregated data from H2O to provide guidance and advocacy, amplifying patient voices on a global scale. 👉 Read how H2O will impact the healthcare system: https://bit.ly/3TTEdfP

🌟🔍 Ever wondered how digital transformation is reshaping healthcare? Global Head of Roche Information Solution, Mr. Moritz Hartmann shares how healthcare providers should adopt the right digital tools, and implement these tools in the right way, to harness their full potential. Dive into the full article to explore how these advancements are set to revolutionize healthcare! 🌟 https://bit.ly/4dhefto    What’s more! - Be sure to catch “Tomorrow’s Health Today: Exploring Digital Transformation in Healthcare” in #HMA2024 in Bali! Sponsored by Roche Diagnostics

The future of healthcare is here, and it's data-driven! Explore the latest trends and advancements in the industry with this informative article from Forbes. #DigitalHealth #TechTrends

The future of healthcare is here, and it's data-driven! Explore the latest trends and advancements in the industry with this informative article from Forbes. #DigitalHealth #TechTrends